Skip to search formSkip to main contentSkip to account menu

EB 1089

Known as: EB-1089, EB1089 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2008
Highly Cited
2008
We have investigated how Wnt and vitamin D receptor signals regulate epidermal differentiation. Many epidermal genes induced by… 
Highly Cited
2005
Highly Cited
2005
A chemotherapeutic vitamin D analogue, EB1089, kills tumor cells via a caspase-independent pathway that results in chromatin… 
Highly Cited
2000
Highly Cited
2000
Vitamin D3 is believed to reduce the risk of colon cancer, and serum levels inversely correlate with colorectal cancer incidence… 
Highly Cited
1999
Highly Cited
1999
The steroid hormone 1,25-dihydroxyvitamin D [1,25(OH)2D, also known as calcitriol] is known to inhibit the proliferation and to… 
Highly Cited
1998
Highly Cited
1998
Preclinical studies have shown that the vitamin D analogue EB 1089 has significantly less calcaemic activity than its parent… 
Highly Cited
1998
Highly Cited
1998
1,25-Dihydroxyvitamin D3 [1,25-(OH)2D3] and its synthetic analog EB1089 induce characteristic morphological features of apoptosis… 
Highly Cited
1998
Highly Cited
1998
The effects of two vitamin D analogues, EB1089 and CB1093, on insulin-like growth factor binding protein (IGFBP) expression have… 
Highly Cited
1997
Highly Cited
1997
Recent studies have suggested that the active metabolite of vitamin D3, 1,25-dihydroxyvitamin D3, can inhibit the growth and/or… 
Highly Cited
1996
Highly Cited
1996